1. |
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
- Gabel, D, et al.
(författare)
-
Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture
- 1997
-
Ingår i: Acta Neurochirurgica. - 0001-6268. ; 139:7, s. 606-612
-
Tidskriftsartikel (refereegranskat)abstract
- The disposition of Na2B12H11SH (BSH) in patients with malignant glioma has been investigated, in preparation for a Phase I clinical trial of boron neutron capture therapy. BSH was found to possess a linear disposition over the dosage interval investigated (up to 75 mg/kg). A bi-phasic blood pharmacokinetics was observed. Tumour-to-blood ratios showed variations between patients between 0.08 and 5.1. The data allow the definition of amount of BSH and timing of infusion for a Phase I clinical trial protocol.
|
|
6. |
|
|
7. |
|
|
8. |
|
|
9. |
|
|